QP Release – expectations and responsibilities for clinical and commercial drug products in Europe
On June 23rd, the webinar “QP Release – expectations and responsibilities for clinical and commercial drug products in Europe” was held.
Veronika Goriachikh, Head of Logistics at GCT, took part in the event, which covered:
- Expectations and responsibilities of the QP for release of drug product for clinical trials and commercial supply in EU;
- Best practices required to efficiently gain QP release – for clinical and commercial products manufactured in North America and other countries outside the EU
and other related topics.
GCT stays up to date with the innovations and changes within the industry, ensuring the highest standard of service for its clients.
Updated: June 24, 2021
Permanent link: https://2022.gctrials.com/posts/qp-release-expectations-and-responsibilities-for-clinical-and-commercial-drug-products-in-europe/